Association of cigarette smoking, obesity, and underlying medical conditions with COVID-19 hospitalization and mortality in Iran: A nationwide retrospective ecological study

Khorrami, Zahra; Nili, Sairan; Sharifi, Hamid; Eybpoosh, Sana; Shokoohi, Mostafa

doi:10.47176/mjiri.34.133

Cited by 6 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, obese patients had a 58% higher risk of experiencing poorer COVID-19 health outcomes. Studies from the MENA region have reported similar results including Kuwait [ 42 ], the Kingdom of Saudi Arabia (KSA) [ 5 ], and Iran [ 43 ]. In fact, the study of interactions between obesity and infectious respiratory diseases began even before the COVID-19 pandemic.…”

Section: Discussionmentioning

confidence: 86%

An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study

Bastaki

Sheek-Hussein

Shukla

et al. 2022

IJERPH

View full text Add to dashboard Cite

The aim of this study was to determine the prevalence of non-communicable diseases and their correlation with COVID-19 disease severity among patients infected in Dubai. Clinical and demographic data were extracted from hospital records of 34,687 COVID-19 patients who visited or were admitted into Dubai hospitals between 28 January 2020 and 30 September 2020. Prevalence of co-morbidities in COVID-19 patients were assessed. The main risk factors associated with COVID-19 disease severity were also identified using three regression models. All co-morbidities were significantly associated with COVID-19 severity in the bivariate analysis (p-value ≤ 0.05) except for vitamin-D deficiency and chronic lower respiratory diseases. Patients with ischemic heart diseases (AOR: 2.08; 95% CI: 1.37, 3.15), pulmonary and other heart diseases (AOR: 2.13; 95% CI: 1.36, 3.32) and chronic kidney diseases (AOR: 1.81; 95% CI: 1.01, 3.25) had higher odds of severe COVID-19 symptoms. Suffering from multiple co-morbidities increased the odds of developing severe COVID-19 symptoms substantially in comparison to having only one co-morbidity i.e., (AOR: 1.52; 95% CI 1.76–2.60) to (AOR: 2.33; 95% CI: 1.37, 3.97). Identifying these risk factors could assist in the early recognition of high-risk populations and ensure the most appropriate preventive measures and required medical management during the pandemic.

show abstract

Section: Discussionmentioning

confidence: 86%

An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study

Bastaki

Sheek-Hussein

Shukla

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…For example, we could not include health behavior characteristics such as smoking status as control variables. Some studies have shown that severity and mortality due to COVID-19 are associated with smoking status [ 37 , 38 ]. Considering that in Korea, smoking prevalence is much higher in males than in females, the absence of a smoking variable might result in confounding the sex difference in the association between the underlying diseases and the risk of belonging to the clinical severity group among COVID-19 patients.…”

Section: Discussionmentioning

confidence: 99%

Sex-Specific Association between Underlying Diseases and the Severity and Mortality Due to COVID-19 Infection: A Retrospective Observational Cohort Analysis of Clinical Epidemiological Information Collected by the Korea Disease Control and Prevention Agency

Kim

Chung

2022

Healthcare

View full text Add to dashboard Cite

This study is a retrospective observational cohort analysis aiming to explore the relationship between underlying disease and the severity and mortality rate of coronavirus disease (COVID-19) by sex. As sample subjects, 5077 confirmed COVID-19 patients were selected. The dependent variable was each patient’s clinical severity, dichotomized into two groups: clinical non-severity group and clinical severity group (including death group). Eleven underlying diseases were considered variables of interest, and each was dichotomized. Binary multivariate logistic regression model analyses were performed. Our results showed that the proportion of male patients (7.1%) in the clinical severity group was significantly higher than that of female patients (4.5%) and that the risk of being in the clinical severity group was higher in patients with specific underlying diseases. The underlying diseases varied: in males, rheumatism and autoimmune (adjusted odds ratio (aOR) = 6.69, 95% confidence interval (CI) = 1.60–27.98), dementia (aOR = 4.09, 95% CI = 2.14–7.82), cancer (aOR = 2.69, 95% CI = 1.27–5.69), and diabetes mellitus (aOR = 1.81, 95% CI = 1.18–2.77); in females, chronic kidney disease (aOR = 5.09, 95% CI = 1.87–13.86), dementia (aOR = 3.08, 95% CI = 1.18–5.23), diabetes mellitus (aOR = 1.87, 95% CI = 1.15–3.02), and hypertension (aOR = 1.73, 95% CI = 1.08–2.78). This study identified certain underlying diseases related to the high risk of being in clinically severe conditions and found that they differ between sexes. Prevention and treatment measure should be developed to reduce severity or mortality in confirmed COVID-19, based on underlying diseases and sex. However, further in-depth research is required to explore whether the findings and suggestions of this study can be generalized to other countries.

show abstract

“…There is strong evidence that tobacco use increases the risks of mortality and disease severity among COVID-19 patients. Ecological studies have explored the relationship between COVID-19 hospitalisation and mortality with smoking [ 5 , 6 ]. Countries and provinces with a higher age-standardized prevalence of tobacco smoking had a higher likelihood of COVID-19 death rates [ 6 ].…”

Section: The Challenges In Covid-19 Recoverymentioning

confidence: 99%

“…Ecological studies have explored the relationship between COVID-19 hospitalisation and mortality with smoking [ 5 , 6 ]. Countries and provinces with a higher age-standardized prevalence of tobacco smoking had a higher likelihood of COVID-19 death rates [ 6 ]. As part of the global COVID-19 recovery and to further avoid smoking-related burden on the pandemic, public health efforts during the pandemic should assist tobacco users in quitting and provide cessation support to tobacco users.…”

Section: The Challenges In Covid-19 Recoverymentioning

confidence: 99%

Tobacco control measures in COVID-19 recovery: an opportune time to restore equity and planetary health

Chen

2022

Environ. Health Prev. Med.

View full text Add to dashboard Cite

Tobacco intersects with the COVID-19 pandemic not only in terms of health consequences, but also environmental change and planetary health. Tobacco use exacerbates inequalities, causes catastrophic environmental degradation and climate change and adds burdens to COVID-19-related mortality, which are major challenges to recovery from the COVID-19 pandemic. However, the pandemic has provided a chance to combat tobacco use and accelerate efforts to alleviate these challenges in response. The MPOWER measures introduced by the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) can play a crucial role in COVID-19 recovery to fight tobacco use and contribute to sustainable and equitable development. To accelerate recovery, it is critical to call for actions for governments and policy-makers to strengthen synergies and coordinate policy actions emphasising tobacco control and cessation across equity, public health, and climate actions as global authorities pledge to achieve the Sustainable Development Goals (SDGs) and net zero emissions targets as part of the Climate Change Conference 2021 (COP26).

show abstract

Association of cigarette smoking, obesity, and underlying medical conditions with COVID-19 hospitalization and mortality in Iran: A nationwide retrospective ecological study

Cited by 6 publications

References 0 publications

An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study

An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study

Sex-Specific Association between Underlying Diseases and the Severity and Mortality Due to COVID-19 Infection: A Retrospective Observational Cohort Analysis of Clinical Epidemiological Information Collected by the Korea Disease Control and Prevention Agency

Tobacco control measures in COVID-19 recovery: an opportune time to restore equity and planetary health

Contact Info

Product

Resources

About